Overview

Evaluation of the Efficacy and Tolerance of Low Doses of Ethosuximide in the Treatment of Peripheral Neuropathic Pain

Status:
Recruiting
Trial end date:
2022-12-12
Target enrollment:
Participant gender:
Summary
Evaluation of the efficacy and tolerance of low doses of ethosuximide in the treatment of peripheral neuropathic pain
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Clermont-Ferrand
Treatments:
Ethosuximide